首页> 美国卫生研究院文献>PLoS Neglected Tropical Diseases >Effective Equine Immunization Protocol for Production of Potent Poly-specific Antisera against Calloselasma rhodostoma Cryptelytrops albolabris and Daboia siamensis
【2h】

Effective Equine Immunization Protocol for Production of Potent Poly-specific Antisera against Calloselasma rhodostoma Cryptelytrops albolabris and Daboia siamensis

机译:有效的马免疫接种方案可产生强效的多特异性抗血清包括抗霜霉病白色隐孢子虫和暹罗黄檀

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Snake envenomation has been estimated to affect 1.8 million people annually with about 94,000 deaths mostly in poor tropical countries. Specific antivenoms are the only rational and effective therapy for these cases. Efforts are being made to produce effective, affordable and sufficient antivenoms for these victims. The immunization process, which has rarely been described in detail, is one step that needs to be rigorously studied and improved especially with regard to the production of polyspecific antisera. The polyspecific nature of therapeutic antivenom could obviate the need to identify the culprit snake species. The aim of this study was to produce potent polyspecific antisera against 3 medically important vipers of Thailand and its neighboring countries, namely Cryptelytrops albolabris "White lipped pit viper" (CA), Calleoselasma rhodostoma “Malayan pit viper” (CR), and Daboia siamensis “Russell’s viper” (DS). Four horses were immunized with a mixture of the 3 viper venoms using the ‘low dose, low volume multi-site’ immunization protocol. The antisera showed rapid rise in ELISA titers against the 3 venoms and reached plateau at about the 8th week post-immunization. The in vivo neutralization potency (P) of the antisera against CA, CR and DS venoms was 10.40, 2.42 and 0.76 mg/ml, respectively and was much higher than the minimal potency limits set by Queen Soavabha Memorial Institute (QSMI). The corresponding potency values for the QSMI monospecific antisera against CA, CR and DS venoms were 7.28, 3.12 and 1.50 mg/ml, respectively. The polyspecific antisera also effectively neutralized the procoagulant, hemorrhagic, necrotic and nephrotoxic activities of the viper venoms. This effective immunization protocol should be useful in the production of potent polyspecific antisera against snake venoms, and equine antisera against tetanus, diphtheria or rabies.
机译:据估计,蛇的毒化每年影响180万人,其中约有94,000人死亡,主要发生在贫穷的热带国家。特定的抗蛇毒血清是这些情况的唯一合理有效的治疗方法。正在努力为这些受害者提供有效,可负担和足够的抗蛇毒血清。很少详细描述的免疫过程是一个需要严格研究和改进的步骤,尤其是在生产多特异性抗血清方面。治疗性抗蛇毒血清的多特异性性质可以消除鉴定罪魁祸首蛇种的需要。这项研究的目的是针对泰国及其邻国的3种医学上重要的毒蛇产生强效的多特异性抗血清,这些毒蛇为白色隐纹蛇(CA),红毛Callooselasma rhodoststoma“马来亚pit蛇”(CR)和暹罗黄檀(Daboia siamensis)。 “罗素的毒蛇”(DS)。使用“低剂量,小体积多部位”免疫方案,用3种蛇毒的混合物对4匹马进行免疫。抗血清显示针对3种毒液的ELISA效价快速升高,并在免疫后第8周达到稳定水平。抗CA,CR和DS毒液的抗血清的体内中和力(P)分别为10.40、2.42和0.76 mg / ml,远高于Soavabha女王纪念研究所(QSMI)设定的最低效价极限。针对CA,CR和DS毒液的QSMI单特异性抗血清的相应效价分别为7.28、3.12和1.50 mg / ml。多特异性抗血清还有效中和了毒蛇毒的促凝血,止血,坏死和肾毒性活性。这种有效的免疫方案应可用于生产有效的抗蛇毒的多特异性抗血清,以及抗破伤风,白喉或狂犬病的马抗血清。

著录项

相似文献

  • 外文文献
  • 中文文献
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号